These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 14596698)

  • 1. Cisplatin-based adjuvant chemotherapy in resected non-small-cell lung cancer.
    Gibson AD
    Clin Lung Cancer; 2003 Jul; 5(1):18-20. PubMed ID: 14596698
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of resected non-small-cell lung cancer.
    Bria E; Giannarelli D; Terzoli E
    N Engl J Med; 2005 Oct; 353(14):1523-4; author reply 1523-4. PubMed ID: 16207858
    [No Abstract]   [Full Text] [Related]  

  • 3. Adjuvant chemotherapy for lung cancer.
    Büyükçelik A; Utkan G; Yalçin B
    N Engl J Med; 2004 Apr; 350(16):1681-3; author reply 1681-3. PubMed ID: 15088318
    [No Abstract]   [Full Text] [Related]  

  • 4. The current status of adjuvant chemotherapy for resected non-small cell lung cancer.
    Socinski MA
    Semin Oncol; 1999 Oct; 26(5 Suppl 15):27-33. PubMed ID: 10566608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy in resected non-small cell lung cancer.
    Cangiano R
    Rays; 2004; 29(4):435-7. PubMed ID: 15852732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preoperative chemotherapy in patients with non-small cell lung cancer].
    Adachi A; Hayashi A; Hayashida R; Hattori R; Nagamatsu Y; Nasu K; Iwanaga D; Takagi K; Ono H; Kakegawa T
    Gan To Kagaku Ryoho; 1993 Apr; 20(5):673-5. PubMed ID: 8385907
    [No Abstract]   [Full Text] [Related]  

  • 7. Adjuvant chemotherapy for lung cancer.
    Ikhlaque N; Baumann MA
    N Engl J Med; 2004 Apr; 350(16):1681-3; author reply 1681-3. PubMed ID: 15084703
    [No Abstract]   [Full Text] [Related]  

  • 8. Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic Program.
    Filipits M; Pirker R; Dunant A; Lantuejoul S; Schmid K; Huynh A; Haddad V; André F; Stahel R; Pignon JP; Soria JC; Popper HH; Le Chevalier T; Brambilla E
    J Clin Oncol; 2007 Jul; 25(19):2735-40. PubMed ID: 17602078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can adjuvant chemotherapy improve survival in patients with early-stage, resected non-small-cell lung cancer?
    Azzoli CG
    Nat Clin Pract Oncol; 2005 Nov; 2(11):552-3. PubMed ID: 16270095
    [No Abstract]   [Full Text] [Related]  

  • 10. Adjuvant chemotherapy for lung cancer--a new standard of care.
    Blum RH
    N Engl J Med; 2004 Jan; 350(4):404-5. PubMed ID: 14736933
    [No Abstract]   [Full Text] [Related]  

  • 11. Adjuvant chemotherapy for lung cancer.
    Feliu J; Espinosa E; Sánchez JJ
    N Engl J Med; 2004 Apr; 350(16):1681-3; author reply 1681-3. PubMed ID: 15088319
    [No Abstract]   [Full Text] [Related]  

  • 12. Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small-cell lung cancer.
    Früh M; Rolland E; Pignon JP; Seymour L; Ding K; Tribodet H; Winton T; Le Chevalier T; Scagliotti GV; Douillard JY; Spiro S; Shepherd FA
    J Clin Oncol; 2008 Jul; 26(21):3573-81. PubMed ID: 18640938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant chemotherapy for lung cancer.
    Morgan GW
    N Engl J Med; 2004 Apr; 350(16):1681-3; author reply 1681-3. PubMed ID: 15088321
    [No Abstract]   [Full Text] [Related]  

  • 14. Adjuvant chemotherapy for lung cancer.
    Sauter C
    N Engl J Med; 2004 Apr; 350(16):1681-3; author reply 1681-3. PubMed ID: 15088320
    [No Abstract]   [Full Text] [Related]  

  • 15. [Does chemotherapy improve the results of postoperative radiotherapy in completely resected stage II and IIIA non-small-cell bronchial cancer?].
    Baumann M
    Strahlenther Onkol; 2001 Apr; 177(4):220-1. PubMed ID: 11370558
    [No Abstract]   [Full Text] [Related]  

  • 16. Non-small-cell lung cancer--stalemate or progress?
    Carney DN; Hansen HH
    N Engl J Med; 2000 Oct; 343(17):1261-2. PubMed ID: 11071679
    [No Abstract]   [Full Text] [Related]  

  • 17. Adjuvant chemotherapy for non-small cell lung cancer: contribution of the International Adjuvant Lung Trial.
    Dunant A; Pignon JP; Le Chevalier T
    Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5017s-5021s. PubMed ID: 16000606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy for radically resected non-small cell lung cancer: a retrospective analysis of 311 consecutively treated patients.
    Dediu M; Horvat T; Tarlea A; Anghel R; Cordos I; Miron G; Iorga P; Alexandru A; Nistor C; Grozavu C; Savu C
    Lung Cancer; 2005 Jan; 47(1):93-101. PubMed ID: 15603859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial.
    Waller D; Peake MD; Stephens RJ; Gower NH; Milroy R; Parmar MK; Rudd RM; Spiro SG
    Eur J Cardiothorac Surg; 2004 Jul; 26(1):173-82. PubMed ID: 15200998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer.
    Imaizumi M;
    Lung Cancer; 2005 Jul; 49(1):85-94. PubMed ID: 15949594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.